Why the study?
Does short-term treatment with ranolazine improve LV mechanical efficiency without increasing myocardial oxygen consumption in dogs with chronic heart failure?
Population
Dogs with chronic heart failure (HF)
Comparison
Short-term treatment with ranolazine vs Dobutamine
Design
Preclinical
Follow-up
short-term
Authors
Loading...
May offer metabolic advantage over dobutamine in experimental HF; hypothesis-generating, requires human trials before clinical consideration.
Does short-term treatment with ranolazine improve LV mechanical efficiency without increasing myocardial oxygen consumption in dogs with chronic heart failure?
In a canine model of heart failure, short-term ranolazine improved LV mechanical efficiency without increasing myocardial oxygen demand, offering a favorable metabolic profile compared to dobutamine.
Chandler et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: